Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Raff

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Biotechniques|September 23, 1997
Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenesT Raff, M van der Giet, D Endemann, et al.
Burns : Journal of the International Society for Burn Injuries|September 19, 2002
Clinical practice of glycerol preserved allograft skin coverageS Blome-Eberwein, A Jester, M Kuentscher, et al.
Leukemia|September 3, 2004
Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantationS Böttcher, M Ritgen, C Pott, et al.
Leukemia|September 28, 2012
Uncovering early, lineage-dependent effects of TPMT genotype in adult acute lymphoblastic leukemia by minimal residual diseaseT Raff, M Kaiser, N Gökbuget, et al.
Leukemia|July 31, 2009
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysisS Böttcher, S Stilgenbauer, R Busch, et al.
Leukemia|October 25, 2003
Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALLT Szczepański, V H J van der Velden, T Raff, et al.
Leukemia|February 13, 2004
Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemiaM Brüggemann, V H J van der Velden, T Raff, et al.
Leukemia|October 8, 2004
TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapseV H J van der Velden, M Brüggemann, P G Hoogeveen, et al.
Leukemia|February 9, 2007
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR dataV H J van der Velden, G Cazzaniga, A Schrauder, et al.
Leukemia|December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008M Brüggemann, A Schrauder, T Raff, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Biotechniques|September 23, 1997
Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenesT Raff, M van der Giet, D Endemann, et al.
Burns : Journal of the International Society for Burn Injuries|September 19, 2002
Clinical practice of glycerol preserved allograft skin coverageS Blome-Eberwein, A Jester, M Kuentscher, et al.
Leukemia|September 3, 2004
Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantationS Böttcher, M Ritgen, C Pott, et al.
Leukemia|September 28, 2012
Uncovering early, lineage-dependent effects of TPMT genotype in adult acute lymphoblastic leukemia by minimal residual diseaseT Raff, M Kaiser, N Gökbuget, et al.
Leukemia|July 31, 2009
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysisS Böttcher, S Stilgenbauer, R Busch, et al.
Leukemia|October 25, 2003
Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALLT Szczepański, V H J van der Velden, T Raff, et al.
Leukemia|February 13, 2004
Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemiaM Brüggemann, V H J van der Velden, T Raff, et al.
Leukemia|October 8, 2004
TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapseV H J van der Velden, M Brüggemann, P G Hoogeveen, et al.
Leukemia|February 9, 2007
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR dataV H J van der Velden, G Cazzaniga, A Schrauder, et al.
Leukemia|December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008M Brüggemann, A Schrauder, T Raff, et al.
Pageof 3